 | • レポートコード：D0804-09696 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療機器・医療消耗品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、患者腫瘍組織移植モデルの世界市場を広く調査・分析し、今後の市場展望をまとめております。患者腫瘍組織移植モデルの種類別市場規模（マウスモデル、ラットモデル）、用途別市場規模（製薬・バイオテクノロジー企業、受託研究機関、学術研究機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Crown Bioscience Inc. (US)、Shanghai LIDE Biotech Co., Ltd (China)、The Jackson Laboratory (US)、WuXi AppTec (China)、EPO Berlin-Buch GmBH (Germany)、Champions Oncology (US)、Horizon Discovery Group PLC (UK)、Charles River Laboratories International (US)、ONCODESIGN (France)、Xentech (France)、Urolead (France)、Explora BioLabs (US) ・地域別グローバル市場分析 2015年-2020年 ・患者腫瘍組織移植モデルの北米市場（アメリカ、カナダ、メキシコ） ・患者腫瘍組織移植モデルのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・患者腫瘍組織移植モデルのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・患者腫瘍組織移植モデルの南米市場（ブラジル、アルゼンチン） ・患者腫瘍組織移植モデルの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：マウスモデル、ラットモデル ・用途別分析：製薬・バイオテクノロジー企業、受託研究機関、学術研究機関 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Patient Derived Xenograft Models market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Patient Derived Xenograft Models market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Patient Derived Xenograft Models market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Patient Derived Xenograft Models market has been segmented into
Mice Models
Rat Models
By Application, Patient Derived Xenograft Models has been segmented into:
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutions
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Patient Derived Xenograft Models market presented in the report. This section sheds light on the sales growth of different regional and country-level Patient Derived Xenograft Models markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Patient Derived Xenograft Models market.
The report offers in-depth assessment of the growth and other aspects of the Patient Derived Xenograft Models market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Patient Derived Xenograft Models Market Share Analysis
Patient Derived Xenograft Models competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Patient Derived Xenograft Models sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Patient Derived Xenograft Models sales, revenue and market share for each player covered in this report.
The major players covered in Patient Derived Xenograft Models are:
Crown Bioscience Inc. (US)
Shanghai LIDE Biotech Co., Ltd (China)
The Jackson Laboratory (US)
WuXi AppTec (China)
EPO Berlin-Buch GmBH (Germany)
Champions Oncology (US)
Horizon Discovery Group PLC (UK)
Charles River Laboratories International (US)
ONCODESIGN (France)
Xentech (France)
Urolead (France)
Explora BioLabs (US)
Among other players domestic and global, Patient Derived Xenograft Models market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Patient Derived Xenograft Models product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Patient Derived Xenograft Models, with price, sales, revenue and global market share of Patient Derived Xenograft Models in 2018 and 2019.
Chapter 3, the Patient Derived Xenograft Models competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Patient Derived Xenograft Models breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Patient Derived Xenograft Models market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Patient Derived Xenograft Models sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Patient Derived Xenograft Models Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Patient Derived Xenograft Models Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Mice Models
1.2.3 Rat Models
1.3 Market Analysis by Application
1.3.1 Overview: Global Patient Derived Xenograft Models Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Contract Research Organizations
1.3.4 Academic & Research Institutions
1.4 Overview of Global Patient Derived Xenograft Models Market
1.4.1 Global Patient Derived Xenograft Models Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Crown Bioscience Inc. (US)
2.1.1 Crown Bioscience Inc. (US) Details
2.1.2 Crown Bioscience Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Crown Bioscience Inc. (US) SWOT Analysis
2.1.4 Crown Bioscience Inc. (US) Product and Services
2.1.5 Crown Bioscience Inc. (US) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Shanghai LIDE Biotech Co., Ltd (China)
2.2.1 Shanghai LIDE Biotech Co., Ltd (China) Details
2.2.2 Shanghai LIDE Biotech Co., Ltd (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Shanghai LIDE Biotech Co., Ltd (China) SWOT Analysis
2.2.4 Shanghai LIDE Biotech Co., Ltd (China) Product and Services
2.2.5 Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 The Jackson Laboratory (US)
2.3.1 The Jackson Laboratory (US) Details
2.3.2 The Jackson Laboratory (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 The Jackson Laboratory (US) SWOT Analysis
2.3.4 The Jackson Laboratory (US) Product and Services
2.3.5 The Jackson Laboratory (US) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 WuXi AppTec (China)
2.4.1 WuXi AppTec (China) Details
2.4.2 WuXi AppTec (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 WuXi AppTec (China) SWOT Analysis
2.4.4 WuXi AppTec (China) Product and Services
2.4.5 WuXi AppTec (China) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 EPO Berlin-Buch GmBH (Germany)
2.5.1 EPO Berlin-Buch GmBH (Germany) Details
2.5.2 EPO Berlin-Buch GmBH (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 EPO Berlin-Buch GmBH (Germany) SWOT Analysis
2.5.4 EPO Berlin-Buch GmBH (Germany) Product and Services
2.5.5 EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Champions Oncology (US)
2.6.1 Champions Oncology (US) Details
2.6.2 Champions Oncology (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Champions Oncology (US) SWOT Analysis
2.6.4 Champions Oncology (US) Product and Services
2.6.5 Champions Oncology (US) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Horizon Discovery Group PLC (UK)
2.7.1 Horizon Discovery Group PLC (UK) Details
2.7.2 Horizon Discovery Group PLC (UK) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Horizon Discovery Group PLC (UK) SWOT Analysis
2.7.4 Horizon Discovery Group PLC (UK) Product and Services
2.7.5 Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Charles River Laboratories International (US)
2.8.1 Charles River Laboratories International (US) Details
2.8.2 Charles River Laboratories International (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Charles River Laboratories International (US) SWOT Analysis
2.8.4 Charles River Laboratories International (US) Product and Services
2.8.5 Charles River Laboratories International (US) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 ONCODESIGN (France)
2.9.1 ONCODESIGN (France) Details
2.9.2 ONCODESIGN (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 ONCODESIGN (France) SWOT Analysis
2.9.4 ONCODESIGN (France) Product and Services
2.9.5 ONCODESIGN (France) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Xentech (France)
2.10.1 Xentech (France) Details
2.10.2 Xentech (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Xentech (France) SWOT Analysis
2.10.4 Xentech (France) Product and Services
2.10.5 Xentech (France) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Urolead (France)
2.11.1 Urolead (France) Details
2.11.2 Urolead (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Urolead (France) SWOT Analysis
2.11.4 Urolead (France) Product and Services
2.11.5 Urolead (France) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Explora BioLabs (US)
2.12.1 Explora BioLabs (US) Details
2.12.2 Explora BioLabs (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Explora BioLabs (US) SWOT Analysis
2.12.4 Explora BioLabs (US) Product and Services
2.12.5 Explora BioLabs (US) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Patient Derived Xenograft Models Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Patient Derived Xenograft Models Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Patient Derived Xenograft Models Manufacturer Market Share in 2019
3.3.2 Top 6 Patient Derived Xenograft Models Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Patient Derived Xenograft Models Sales, Revenue and Market Share by Regions
4.1.1 Global Patient Derived Xenograft Models Sales and Market Share by Regions (2015-2020)
4.1.2 Global Patient Derived Xenograft Models Revenue and Market Share by Regions (2015-2020)
4.2 North America Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
4.3 Europe Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
4.5 South America Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Patient Derived Xenograft Models Sales, Revenue and Market Share by Country
5.1.1 North America Patient Derived Xenograft Models Sales and Market Share by Country (2015-2020)
5.1.2 North America Patient Derived Xenograft Models Revenue and Market Share by Country (2015-2020)
5.2 United States Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
5.3 Canada Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
5.4 Mexico Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Patient Derived Xenograft Models Sales, Revenue and Market Share by Country
6.1.1 Europe Patient Derived Xenograft Models Sales and Market Share by Country (2015-2020)
6.1.2 Europe Patient Derived Xenograft Models Revenue and Market Share by Country (2015-2020)
6.2 Germany Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
6.3 UK Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
6.4 France Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
6.5 Russia Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
6.6 Italy Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Patient Derived Xenograft Models Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Patient Derived Xenograft Models Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Patient Derived Xenograft Models Revenue and Market Share by Regions (2015-2020)
7.2 China Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
7.3 Japan Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
7.4 Korea Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
7.5 India Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
7.7 Australia Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Patient Derived Xenograft Models Sales, Revenue and Market Share by Country
8.1.1 South America Patient Derived Xenograft Models Sales and Market Share by Country (2015-2020)
8.1.2 South America Patient Derived Xenograft Models Revenue and Market Share by Country (2015-2020)
8.2 Brazil Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
8.3 Argentina Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Patient Derived Xenograft Models Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Patient Derived Xenograft Models Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Patient Derived Xenograft Models Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
9.3 Turkey Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
9.4 Egypt Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
9.5 South Africa Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Patient Derived Xenograft Models Sales and Market Share by Type (2015-2020)
10.2 Global Patient Derived Xenograft Models Revenue and Market Share by Type (2015-2020)
10.3 Global Patient Derived Xenograft Models Price by Type (2015-2020)
11 Global Patient Derived Xenograft Models Market Segment by Application
11.1 Global Patient Derived Xenograft Models Sales Market Share by Application (2015-2020)
11.2 Global Patient Derived Xenograft Models Revenue Market Share by Application (2015-2020)
11.3 Global Patient Derived Xenograft Models Price by Application (2015-2020)
12 Market Forecast
12.1 Global Patient Derived Xenograft Models Sales, Revenue and Growth Rate (2021-2025)
12.2 Patient Derived Xenograft Models Market Forecast by Regions (2021-2025)
12.2.1 North America Patient Derived Xenograft Models Market Forecast (2021-2025)
12.2.2 Europe Patient Derived Xenograft Models Market Forecast (2021-2025)
12.2.3 Asia-Pacific Patient Derived Xenograft Models Market Forecast (2021-2025)
12.2.4 South America Patient Derived Xenograft Models Market Forecast (2021-2025)
12.2.5 Middle East & Africa Patient Derived Xenograft Models Market Forecast (2021-2025)
12.3 Patient Derived Xenograft Models Market Forecast by Type (2021-2025)
12.3.1 Global Patient Derived Xenograft Models Sales Forecast by Type (2021-2025)
12.3.2 Global Patient Derived Xenograft Models Market Share Forecast by Type (2021-2025)
12.4 Patient Derived Xenograft Models Market Forecast by Application (2021-2025)
12.4.1 Global Patient Derived Xenograft Models Sales Forecast by Application (2021-2025)
12.4.2 Global Patient Derived Xenograft Models Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Patient Derived Xenograft Models Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Patient Derived Xenograft Models by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Patient Derived Xenograft Models Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Crown Bioscience Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 8. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Major Business
Table 9. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 10. Crown Bioscience Inc. (US) SWOT Analysis
Table 11. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Product and Services
Table 12. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Shanghai LIDE Biotech Co., Ltd (China) Basic Information, Manufacturing Base and Competitors
Table 14. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Major Business
Table 15. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 16. Shanghai LIDE Biotech Co., Ltd (China) SWOT Analysis
Table 17. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Product and Services
Table 18. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. The Jackson Laboratory (US) Basic Information, Manufacturing Base and Competitors
Table 20. The Jackson Laboratory (US) Patient Derived Xenograft Models Major Business
Table 21. The Jackson Laboratory (US) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 22. The Jackson Laboratory (US) SWOT Analysis
Table 23. The Jackson Laboratory (US) Patient Derived Xenograft Models Product and Services
Table 24. The Jackson Laboratory (US) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. WuXi AppTec (China) Basic Information, Manufacturing Base and Competitors
Table 26. WuXi AppTec (China) Patient Derived Xenograft Models Major Business
Table 27. WuXi AppTec (China) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 28. WuXi AppTec (China) SWOT Analysis
Table 29. WuXi AppTec (China) Patient Derived Xenograft Models Product and Services
Table 30. WuXi AppTec (China) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. EPO Berlin-Buch GmBH (Germany) Basic Information, Manufacturing Base and Competitors
Table 32. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Major Business
Table 33. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 34. EPO Berlin-Buch GmBH (Germany) SWOT Analysis
Table 35. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Product and Services
Table 36. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Champions Oncology (US) Basic Information, Manufacturing Base and Competitors
Table 38. Champions Oncology (US) Patient Derived Xenograft Models Major Business
Table 39. Champions Oncology (US) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 40. Champions Oncology (US) SWOT Analysis
Table 41. Champions Oncology (US) Patient Derived Xenograft Models Product and Services
Table 42. Champions Oncology (US) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Horizon Discovery Group PLC (UK) Basic Information, Manufacturing Base and Competitors
Table 44. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Major Business
Table 45. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 46. Horizon Discovery Group PLC (UK) SWOT Analysis
Table 47. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Product and Services
Table 48. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Charles River Laboratories International (US) Basic Information, Manufacturing Base and Competitors
Table 50. Charles River Laboratories International (US) Patient Derived Xenograft Models Major Business
Table 51. Charles River Laboratories International (US) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 52. Charles River Laboratories International (US) SWOT Analysis
Table 53. Charles River Laboratories International (US) Patient Derived Xenograft Models Product and Services
Table 54. Charles River Laboratories International (US) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. ONCODESIGN (France) Basic Information, Manufacturing Base and Competitors
Table 56. ONCODESIGN (France) Patient Derived Xenograft Models Major Business
Table 57. ONCODESIGN (France) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 58. ONCODESIGN (France) SWOT Analysis
Table 59. ONCODESIGN (France) Patient Derived Xenograft Models Product and Services
Table 60. ONCODESIGN (France) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Xentech (France) Basic Information, Manufacturing Base and Competitors
Table 62. Xentech (France) Patient Derived Xenograft Models Major Business
Table 63. Xentech (France) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 64. Xentech (France) SWOT Analysis
Table 65. Xentech (France) Patient Derived Xenograft Models Product and Services
Table 66. Xentech (France) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Urolead (France) Basic Information, Manufacturing Base and Competitors
Table 68. Urolead (France) Patient Derived Xenograft Models Major Business
Table 69. Urolead (France) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 70. Urolead (France) SWOT Analysis
Table 71. Urolead (France) Patient Derived Xenograft Models Product and Services
Table 72. Urolead (France) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Explora BioLabs (US) Basic Information, Manufacturing Base and Competitors
Table 74. Explora BioLabs (US) Patient Derived Xenograft Models Major Business
Table 75. Explora BioLabs (US) Patient Derived Xenograft Models Total Revenue (USD Million) (2018-2019)
Table 76. Explora BioLabs (US) SWOT Analysis
Table 77. Explora BioLabs (US) Patient Derived Xenograft Models Product and Services
Table 78. Explora BioLabs (US) Patient Derived Xenograft Models Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Patient Derived Xenograft Models Sales by Manufacturer (2018-2019) (K Units)
Table 80. Global Patient Derived Xenograft Models Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Patient Derived Xenograft Models Sales by Regions (2015-2020) (K Units)
Table 82. Global Patient Derived Xenograft Models Sales Market Share by Regions (2015-2020)
Table 83. Global Patient Derived Xenograft Models Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Patient Derived Xenograft Models Sales by Countries (2015-2020) (K Units)
Table 85. North America Patient Derived Xenograft Models Sales Market Share by Countries (2015-2020)
Table 86. North America Patient Derived Xenograft Models Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Patient Derived Xenograft Models Revenue Market Share by Countries (2015-2020)
Table 88. Europe Patient Derived Xenograft Models Sales by Countries (2015-2020) (K Units)
Table 89. Europe Patient Derived Xenograft Models Sales Market Share by Countries (2015-2020)
Table 90. Europe Patient Derived Xenograft Models Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Patient Derived Xenograft Models Sales by Regions (2015-2020) (K Units)
Table 92. Asia-Pacific Patient Derived Xenograft Models Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Patient Derived Xenograft Models Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Patient Derived Xenograft Models Sales by Countries (2015-2020) (K Units)
Table 95. South America Patient Derived Xenograft Models Sales Market Share by Countries (2015-2020)
Table 96. South America Patient Derived Xenograft Models Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Patient Derived Xenograft Models Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Patient Derived Xenograft Models Sales by Countries (2015-2020) (K Units)
Table 99. Middle East & Africa Patient Derived Xenograft Models Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Patient Derived Xenograft Models Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Patient Derived Xenograft Models Revenue Market Share by Countries (2015-2020)
Table 102. Global Patient Derived Xenograft Models Sales by Type (2015-2020) (K Units)
Table 103. Global Patient Derived Xenograft Models Sales Share by Type (2015-2020)
Table 104. Global Patient Derived Xenograft Models Revenue by Type (2015-2020) (USD Million)
Table 105. Global Patient Derived Xenograft Models Revenue Share by Type (2015-2020)
Table 106. Global Patient Derived Xenograft Models Sales by Application (2015-2020) (K Units)
Table 107. Global Patient Derived Xenograft Models Sales Share by Application (2015-2020)
Table 108. Global Patient Derived Xenograft Models Sales Forecast by Regions (2021-2025) (K Units)
Table 109. Global Patient Derived Xenograft Models Market Share Forecast by Regions (2021-2025)
Table 110. Global Patient Derived Xenograft Models Sales Forecast by Type (2021-2025) (K Units)
Table 111. Global Patient Derived Xenograft Models Market Share Forecast by Type (2021-2025)
Table 112. Global Patient Derived Xenograft Models Sales Forecast by Application (2021-2025)
Table 113. Global Patient Derived Xenograft Models Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Patient Derived Xenograft Models Picture
Figure 2. Global Sales Market Share of Patient Derived Xenograft Models by Type in 2019
Figure 3. Mice Models Picture
Figure 4. Rat Models Picture
Figure 5. Patient Derived Xenograft Models Sales Market Share by Application in 2018
Figure 6. Pharmaceutical & Biotechnology Companies Picture
Figure 7. Contract Research Organizations Picture
Figure 8. Academic & Research Institutions Picture
Figure 9. Global Patient Derived Xenograft Models Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Patient Derived Xenograft Models Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Patient Derived Xenograft Models Sales Market Share by Manufacturer in 2019
Figure 30. Global Patient Derived Xenograft Models Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Patient Derived Xenograft Models Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Patient Derived Xenograft Models Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Patient Derived Xenograft Models Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Patient Derived Xenograft Models Revenue Market Share by Regions (2015-2020)
Figure 37. Global Patient Derived Xenograft Models Revenue Market Share by Regions in 2018
Figure 38. North America Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
Figure 39. Europe Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
Figure 41. South America Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Patient Derived Xenograft Models Sales and Growth Rate (2015-2020)
Figure 43. North America Patient Derived Xenograft Models Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Patient Derived Xenograft Models Sales Market Share by Countries (2015-2020)
Figure 45. North America Patient Derived Xenograft Models Sales Market Share by Countries in 2018
Figure 46. North America Patient Derived Xenograft Models Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Patient Derived Xenograft Models Revenue Market Share by Countries in 2018
Figure 48. United States Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Patient Derived Xenograft Models Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Patient Derived Xenograft Models Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Patient Derived Xenograft Models Revenue Market Share by Countries in 2019
Figure 54. Germany Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Patient Derived Xenograft Models Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Patient Derived Xenograft Models Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Patient Derived Xenograft Models Revenue Market Share by Regions 2019
Figure 62. China Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Patient Derived Xenograft Models Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Patient Derived Xenograft Models Sales Market Share by Countries in 2019
Figure 69. South America Patient Derived Xenograft Models Revenue Market Share by Countries in 2019
Figure 70. Brazil Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Patient Derived Xenograft Models Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Patient Derived Xenograft Models Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Patient Derived Xenograft Models Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Patient Derived Xenograft Models Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Patient Derived Xenograft Models Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Patient Derived Xenograft Models Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Patient Derived Xenograft Models Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Patient Derived Xenograft Models Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Patient Derived Xenograft Models Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Patient Derived Xenograft Models Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Patient Derived Xenograft Models Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Patient Derived Xenograft Models Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
化学モデルの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Chemistry Models market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chemistry Models market repo…- スケルトンモデルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Skeleton Models market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Skeleton Models market report…
- 生物学モデルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Biology Models market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Biology Models market report p…
- 解剖モデルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Anatomical Models market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 植物由来タンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Plant Derived Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Plant Derived Protein m…